Compare WYETH LTD with Pfizer - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs PFIZER - Comparison Results

WYETH LTD     Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD PFIZER WYETH LTD/
PFIZER
 
P/E (TTM) x 27.7 33.4 82.9% View Chart
P/BV x 5.3 5.6 95.4% View Chart
Dividend Yield % 1.3 0.6 209.4%  

Financials

 WYETH LTD   PFIZER
EQUITY SHARE DATA
    WYETH LTD
Mar-13
PFIZER
Mar-18
WYETH LTD/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,0442,365 44.2%   
Low Rs8181,625 50.3%   
Sales per share (Unadj.) Rs298.6430.3 69.4%  
Earnings per share (Unadj.) Rs57.278.7 72.7%  
Cash flow per share (Unadj.) Rs58.493.2 62.7%  
Dividends per share (Unadj.) Rs17.0020.00 85.0%  
Dividend yield (eoy) %1.81.0 182.1%  
Book value per share (Unadj.) Rs249.5586.5 42.5%  
Shares outstanding (eoy) m22.7245.75 49.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.14.6 67.3%   
Avg P/E ratio x16.325.3 64.2%  
P/CF ratio (eoy) x15.921.4 74.5%  
Price / Book Value ratio x3.73.4 109.7%  
Dividend payout %29.725.4 116.9%   
Avg Mkt Cap Rs m21,15791,271 23.2%   
No. of employees `0000.52.6 18.7%   
Total wages/salary Rs m4003,143 12.7%   
Avg. sales/employee Rs Th13,787.47,484.8 184.2%   
Avg. wages/employee Rs Th813.01,195.0 68.0%   
Avg. net profit/employee Rs Th2,643.31,369.1 193.1%   
INCOME DATA
Net Sales Rs m6,78319,685 34.5%  
Other income Rs m3531,143 30.9%   
Total revenues Rs m7,13620,828 34.3%   
Gross profit Rs m1,6175,003 32.3%  
Depreciation Rs m27663 4.0%   
Interest Rs m64 131.0%   
Profit before tax Rs m1,9385,479 35.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m6321,878 33.7%   
Profit after tax Rs m1,3013,601 36.1%  
Gross profit margin %23.825.4 93.8%  
Effective tax rate %32.634.3 95.2%   
Net profit margin %19.218.3 104.8%  
BALANCE SHEET DATA
Current assets Rs m6,98424,167 28.9%   
Current liabilities Rs m2,0569,544 21.5%   
Net working cap to sales %72.674.3 97.8%  
Current ratio x3.42.5 134.2%  
Inventory Days Days9955 180.2%  
Debtors Days Days2429 83.4%  
Net fixed assets Rs m2449,514 2.6%   
Share capital Rs m227458 49.7%   
"Free" reserves Rs m5,44126,375 20.6%   
Net worth Rs m5,66826,832 21.1%   
Long term debt Rs m2525 100.0%   
Total assets Rs m7,90136,900 21.4%  
Interest coverage x353.31,305.5 27.1%   
Debt to equity ratio x00 473.4%  
Sales to assets ratio x0.90.5 160.9%   
Return on assets %16.59.8 169.2%  
Return on equity %22.913.4 171.0%  
Return on capital %34.020.4 166.8%  
Exports to sales %0.20-   
Imports to sales %36.30-   
Exports (fob) Rs m15NA-   
Imports (cif) Rs m2,465NA-   
Fx inflow Rs m1522 67.9%   
Fx outflow Rs m2,6771,489 179.8%   
Net fx Rs m-2,662-1,466 181.5%   
CASH FLOW
From Operations Rs m9233,318 27.8%  
From Investments Rs m317-2,383 -13.3%  
From Financial Activity Rs m-481-1,104 43.6%  
Net Cashflow Rs m759-169 -450.5%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 63.9 80.0%  
Indian inst/Mut Fund % 11.3 7.5 150.7%  
FIIs % 7.2 4.9 146.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 23.7 128.3%  
Shareholders   21,978 85,207 25.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   TTK HEALTHCARE  UNICHEM LAB  DR. REDDYS LAB  ELDER PHARMA  ALEMBIC LTD  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex's Journey From 640 Points Down to 2,000 Points Up(Podcast)

What a week it was! While crude oil prices dragged the Indian stock markets lower, finance minister Nirmala Sitharaman's boosters sent markets soaring and how!

Related Views on News

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (3QFY19); Net Profit Up 51.2% (Quarterly Result Update)

Jan 25, 2019 | Updated on Jan 25, 2019

For the quarter ended December 2018, PFIZER has posted a net profit of Rs 1 bn (up 51.2% YoY). Sales on the other hand came in at Rs 5 bn (up 12.5% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of PFIZER for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PFIZER. Also includes updates on the valuation of PFIZER.

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - LUPIN COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS